215 related articles for article (PubMed ID: 26671747)
21. Effects of Helicobacter pylori infection on genetic instability, the aberrant CpG island methylation status and the cellular phenotype in Barrett's esophagus in a Japanese population.
Moriichi K; Watari J; Das KM; Tanabe H; Fujiya M; Ashida T; Kohgo Y
Int J Cancer; 2009 Mar; 124(6):1263-9. PubMed ID: 19048617
[TBL] [Abstract][Full Text] [Related]
22. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.
Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T
Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of Helicobacter pylori eradication for precancerous lesions of the gastric remnant.
Sakakibara M; Ando T; Ishiguro K; Maeda O; Watanabe O; Hirayama Y; Morise K; Maeda K; Matsushita M; Furukawa K; Funasaka K; Nakamura M; Miyahara R; Goto H
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():60-4. PubMed ID: 25521735
[TBL] [Abstract][Full Text] [Related]
24. Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication.
Jung S; Park CH; Kim EH; Shin SJ; Chung H; Lee H; Park JC; Shin SK; Lee YC; Lee SK
J Gastroenterol Hepatol; 2015 Jan; 30(1):75-81. PubMed ID: 25088761
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of Primary and Metachronous Gastric Cancers Discovered after
Maehata Y; Nakamura S; Esaki M; Ikeda F; Moriyama T; Hida R; Washio E; Umeno J; Hirahashi M; Kitazono T; Matsumoto T
Gut Liver; 2017 Sep; 11(5):628-634. PubMed ID: 28395508
[TBL] [Abstract][Full Text] [Related]
26. Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection.
Kato M; Asaka M; Ono S; Nakagawa M; Nakagawa S; Shimizu Y; Chuma M; Kawakami H; Komatsu Y; Hige S; Takeda H
J Gastroenterol; 2007 Jan; 42 Suppl 17():16-20. PubMed ID: 17238020
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication.
Noh G; Kim N; Choi Y; Lee HS; Hwang YJ; Kim HJ; Yoon H; Shin CM; Park YS; Lee DH
J Gastroenterol Hepatol; 2020 Sep; 35(9):1540-1548. PubMed ID: 32090375
[TBL] [Abstract][Full Text] [Related]
28. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma.
Choi J; Kim SG; Yoon H; Im JP; Kim JS; Kim WH; Jung HC
Clin Gastroenterol Hepatol; 2014 May; 12(5):793-800.e1. PubMed ID: 24100112
[TBL] [Abstract][Full Text] [Related]
29. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis.
Yoon SB; Park JM; Lim CH; Cho YK; Choi MG
Helicobacter; 2014 Aug; 19(4):243-8. PubMed ID: 25056262
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of metachronous recurrence of gastric epithelial neoplasia based on Helicobacter pylori infection status and microsatellite stability.
Kim YJ; Kim J; Chung WC
Korean J Intern Med; 2022 Jul; 37(4):768-776. PubMed ID: 35508936
[TBL] [Abstract][Full Text] [Related]
31. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.
Watari J; Tanaka A; Tanabe H; Sato R; Moriichi K; Zaky A; Okamoto K; Maemoto A; Fujiya M; Ashida T; Das KM; Kohgo Y
J Clin Pathol; 2007 Aug; 60(8):921-6. PubMed ID: 16997920
[TBL] [Abstract][Full Text] [Related]
32. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication.
Kodama M; Murakami K; Okimoto T; Sato R; Uchida M; Abe T; Shiota S; Nakagawa Y; Mizukami K; Fujioka T
J Gastroenterol; 2012 Apr; 47(4):394-403. PubMed ID: 22138891
[TBL] [Abstract][Full Text] [Related]
33. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
[TBL] [Abstract][Full Text] [Related]
34. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
[TBL] [Abstract][Full Text] [Related]
35. Successful Eradication of Helicobacter pylori Could Prevent Metachronous Gastric Cancer: A Propensity Matching Analysis.
Nakata R; Nagami Y; Hashimoto A; Sakai T; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Ohira M; Taira K; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y
Digestion; 2021; 102(2):236-245. PubMed ID: 31678978
[TBL] [Abstract][Full Text] [Related]
36. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
[TBL] [Abstract][Full Text] [Related]
37. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the differences in structural chromosomal aberrations of the gastric mucosa between H. pylori positive and negative gastric cancer patients: involvement of H. pylori in the onset of gastric cancer and examination of the mechanism in gastric carcinogenesis following H. pylori eradication.
Ohara T; Kasanuki J; Ohara H; Kanoh Y; Suzuki H; Hashimoto H; Chiba T; Morishita T; Hibi T
Oncol Rep; 2006 Dec; 16(6):1333-42. PubMed ID: 17089058
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
40. The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori Eradication.
Hwang YJ; Choi Y; Kim N; Lee HS; Yoon H; Shin CM; Park YS; Lee DH
Dig Dis Sci; 2022 Jul; 67(7):3055-3066. PubMed ID: 34365533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
